These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7772081)

  • 1. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
    Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
    Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose--Response Study of Colestipol Tablets in Patients with Moderate Hypercholesterolemia.
    Hunninghake DB; Stein EA; Bremner WF; Greenland P; Demke DM; Oliphant TH
    Am J Ther; 1995 Mar; 2(3):180-189. PubMed ID: 11847550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.
    Superko HR; Greenland P; Manchester RA; Andreadis NA; Schectman G; West NH; Hunninghake D; Haskell WL; Probstfield JL
    Am J Cardiol; 1992 Jul; 70(2):135-40. PubMed ID: 1626496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
    Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
    Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
    Lyons D; Webster J; Fowler G; Petrie JC
    Br J Clin Pharmacol; 1994 Jan; 37(1):59-62. PubMed ID: 8148218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
    Davidson M; Ma P; Stein EA; Gotto AM; Raza A; Chitra R; Hutchinson H
    Am J Cardiol; 2002 Feb; 89(3):268-75. PubMed ID: 11809427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
    Korhonen T; Hannuksela ML; Seppänen S; Kervinen K; Kesäniemi YA; Savolainen MJ
    Eur J Clin Pharmacol; 1999 Feb; 54(12):903-10. PubMed ID: 10192749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet.
    Knopp RH; Retzlaff BM; Walden CE; Dowdy AA; Tsunehara CH; Austin MA; Nguyen T
    J Am Coll Nutr; 1997 Dec; 16(6):551-61. PubMed ID: 9430083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H; Rhyne J; Abby S; Lai YL; Jones M
    Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
    N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F; Keller C; Wolfram G
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.